• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

AI vs. Humans: AI Solution Beats Stanford Radiologists In Chest X-ray Diagnostics Competition

Share:

August 27, 2019

JF Healthcare, a Nanchang, China-based medical diagnostic startup is the first organization in the world to beat Stanford University radiologists in a competition designed by the Stanford Machine Learning group to compare the capability of artificial intelligence (AI) to human experts in interpreting chest x-rays.

The AI team from JF Healthcare recently achieved an average AUC score (a measure of diagnostic accuracy) of 0.926 and is currently ranked No. 1 in the world on Stanford’s CheXpert leaderboard. Significantly, the JF team outperforms all three Stanford radiologists on the test set, demonstrating the role that AI can play in providing precise medical diagnostics, especially in underserved areas of the world, with profound implications for the treatment of lung cancer, tuberculosis and other diseases of the thorax.

JF Healthcare Background

Founded in 2015 by former Siemens healthcare executive Frank Wu, JF offers remote diagnostic services, focusing on chest x-rays, for rural township hospitals in China where certified radiologists are often not available. Its mobile screening truck is expected to screen more than ten provinces in China for tuberculosis by the end of 2019, offering a half-million people the possibility of early detection while preventing the spread of disease to broader populations.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

JF plans to develop a chest x-ray screening product to simultaneously screen for tuberculosis, lung cancer, and pneumonia, covering the major thorax diseases based on more than 300,000 chest x-ray images with curated radiology reports collected from approximately 1,000 township hospitals. The team is hoping to fully leverage the clinical value of chest x-rays through AI and deliver it to the massive township hospital patient population in China where radiologists are most needed.

Why It Matters

“The goal is to be better than the best human in making diagnoses and deliver low-cost care with a level of quality that is equivalent to the best hospitals in the world. To do that, the secret is not math; it’s a huge volume of well-curated data,” said Wu, JF Healthcare’s Founder and CEO. “There are 3 billion people in the world without access to quality healthcare. The first step in remedying this problem is providing extremely accurate diagnostics, which is at the core of our strategy and mission.”

Date: August 27, 2019

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • The 53 Digital Health Mergers and Acquisitions We Covered in 2019The 53 Digital Health Mergers and Acquisitions We Covered in 2019
  • Liva Healthcare Wins EU Funding to Help Treat Pregnant Women at Risk of Type 2 DiabetesLiva Healthcare Wins EU Funding to Help Treat Pregnant Women at Risk of Type 2 Diabetes
  • Livongo Taps MDLive, Doctor on Demand for Virtual Care IntegrationLivongo Taps MDLive, Doctor on Demand for Virtual Care Integration
  • Varian Expands Cancer Care Portfolio with Noona Healthcare AcquisitionVarian Expands Cancer Care Portfolio with Noona Healthcare Acquisition
  • Big tech poised to beat healthcare in reaping value from artificial intelligence, report saysBig tech poised to beat healthcare in reaping value from artificial intelligence, report says
  • AMIA Backs NIH Data Sharing Policy, Calls for Phased ImplementationAMIA Backs NIH Data Sharing Policy, Calls for Phased Implementation
  • 21st Century Oncology to Join Australia’s GenesisCare in a Partnership to Increase Access to High Quality Cancer Care in U.S. Communities21st Century Oncology to Join Australia’s GenesisCare in a Partnership to Increase Access to High Quality Cancer Care in U.S. Communities
  • Brightree to Acquire Technology Provider Snapworx, Expanding CPAP Resupply Offerings for Hme ProvidersBrightree to Acquire Technology Provider Snapworx, Expanding CPAP Resupply Offerings for Hme Providers

Trending This Week

  • EHR Vendor Cerner Eyes Developing a $1 Billion Data Business
  • Astonishing Growth in Global Pharmaceutical Market Which is Growing Exponentially with the Major Key Players in the Market Within the Forecast Period 2020-2027
  • Healthcare E-Commerce Market Demand, Insights and Forecast up to 2024
  • Starting the Year Dropping Cash – Two Companies Scooped Up This Week
  • Acquisitions of Biotech Startups Increased in 2020, With No Signs of Slowing Down
  • CareDx Agrees to Acquire Transchart and Expands EMR Connectivity to Over 90 Centersacquisition Will Build on CareDx’s Digital Capabilities and Continue Deepening the Moat with Transplant Centers

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications